[Pathophysiological investigations of Schistosoma mansoni infection in Mastomys natalensis under chemotherapy with a nitrovinylfuran derivative (SQ 18.506) (author's transl)].
D000284:Administration, Oral; D000818:Animals; D004353:Drug Evaluation, Preclinical; D004804:Eosinophils; D005260:Female; D007958:Leukocyte Count; D008099:Liver / Q000503:physiopathology; D008297:Male; D010069:Oxadiazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D012550:Schistosoma mansoni / Q000187:drug effects* / Q000302:isolation & purification; D012552:Schistosomiasis / Q000097:blood / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology*; D013385:Succinate Dehydrogenase / Q000097:blood; D013997:Time Factors
D010069:Oxadiazoles; D013385:Succinate Dehydrogenase
Pathophysiologische Untersuchungen an der Schistosoma mansoni-Infektion der Mastomys natalensis unter der Chemotherapie mit einem Nitrovinylfuran-Derivat (SQ 18.506)